Thermo Fisher Scientific released Chromeleon 7.4, a unified chromatography and mass spectrometry data system that supports single-quad, triple-quad, and HRAM instruments and adds centralized storage, remote access, audit trails, and e-signatures for GxP/21 CFR Part 11 compliance in biopharma, food safety, and environmental labs, according to a press release.
Chromeleon 7.4 is built for networked deployments, consolidating chromatography and targeted MS workflows under one interface across SQ, QQQ, and HRAM instruments. The release adds concurrency and network-failure protection for multiuser labs and introduces tools such as single-scan fragment visualization, simulated isotopic patterns, and multi-consensus reporting to support quantitative screening, Thermo Fisher says. Target applications include biopharma as well as PFAS and pesticide testing in environmental and food labs, with centralized storage and remote instrument control for traceable, compliant operations.
Thermo Fisher says the enterprise rollout is meant to replace workstation-bound MS packages with an IT-managed deployment that standardizes user/role management, audit trails, and e-signatures to meet GxP/21 CFR Part 11. A single interface spans SQ, QQQ, and HRAM instruments across sites, with centralized storage, remote instrument control/data access, and safeguards for concurrency and network failures to maintain data integrity. The company says Chromeleon 7.4 is available as of Sept. 30, 2025.
The company positions Chromeleon 7.4 as a way to standardize MS data handling across sites and instruments without shuttling files between PCs. Admins can centralize user roles and permissions, enforce audit trails and e-signatures, and retain full data provenance, while analysts access runs remotely through a single interface. For targeted quant/confirmatory work, the release adds single-scan fragment views, simulated isotopic patterns, and multi-consensus reporting to support result verification. Thermo Fisher says the platform is suited to regulated workflows (GxP/21 CFR Part 11) and nonregulated screening alike, with initial focus areas including biopharma release testing and environmental/food monitoring such as PFAS and pesticide analysis.
